Law & Safety

Legal Status and Safety

Key point: Neither TB-500 nor thymosin beta-4 has a marketing authorisation for human or veterinary use in the EU, the UK or the US. Offering either as a treatment breaks medicines law.

TB-500 is easy to find for sale, which leads many people to assume it is regulated like a supplement or a drug. It is neither. This page covers the legal position and the gaps in safety knowledge.

Medicines Law

EU: a substance offered to treat or prevent disease counts as a medicinal product and needs an authorisation before sale. No such authorisation exists for TB-500 or thymosin beta-4. Veterinary use is governed by similar rules.
UK: the MHRA has not licensed any product containing these peptides.
US: the FDA has not approved TB-500 or thymosin beta-4 for any condition. Eye drops based on thymosin beta-4 remain investigational.
Elsewhere: import and possession rules for research peptides vary by country. Check the law that applies to you.

Prohibited in Sport

The World Anti-Doping Agency's Prohibited List names "thymosin-β4 and its derivatives, e.g. TB-500" under S2, peptide hormones and growth factors. They are banned at all times. Horse racing authorities also prohibit the peptide, and testing laboratories have developed methods to detect it and its breakdown products in blood and urine.

Why Safety Remains Unclear

No human studies of TB-500. The only human safety data come from trials of the full 43-amino-acid protein, mostly given as eye drops, skin gels or short courses of infusions.
Unknown long-term effects. No study has followed people who used either molecule for long periods.
Theoretical concerns. Thymosin beta-4 promotes cell movement and new blood vessel growth. Researchers have discussed whether this could matter for cancer, but the question has not been settled.
Variable quality. Material sold for research is not produced under medicine manufacturing standards, so identity, purity and contamination are not guaranteed.

Research Chemical, Not a Treatment

A vial marked "research use only" is intended for laboratory experiments under proper supervision. It has no approved dose, no patient information and no regulatory oversight. Labs should handle it according to their institutional procedures and national rules.

Conclusion

TB-500 is an unapproved, prohibited research peptide with almost no data of its own in living organisms. People with injuries should consult a doctor about properly tested treatments.

This information is general in nature and does not constitute legal or medical advice.